ADJUVANT

作品数：496被引量：1918H指数：20
导出分析报告
相关领域：医药卫生更多>>
相关作者：郭虹陈观今郑焕钦许小琴饶平凡更多>>
相关机构：中山大学吉林大学第二军医大学福州大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划中国博士后科学基金高等学校学科创新引智计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Hepatobiliary Surgery and Nutritionx
共 条 记 录，以下是1-9
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion:a multi-center real world study
《Hepatobiliary Surgery and Nutrition》2024年第4期616-631,I0022-I0024,共19页Jingzhong Ouyang Yi Yang Yanzhao Zhou Xu Chang Zhengzheng Wang Qingjun Li Yu Tang Jianqiang Cai Jinxue Zhou Zhen Huang Hong Zhao 
Henan Provincial Medical Science and Technology Research Project(LLRGJ20220191);Key Scientific Research Project of Colleges and Universities in Henan Province(23A320033);Henan Provincial Science and Technology Project(232102311080);National Natural Science Foundation of China(82141127);CAMS Innovation Fund for Medical Sciences(CIFMS)(2021-I2M-C&T-B-057);National Key Research and Development Program of China(2023YFC3403800);e Natural Science Foundation of Shandong Province(ZR2020QH177).
Background:It is well known that laparoscopic liver surgery can offer advantages over open liver surgery in selected patients.However,what type of procedures can benefit most from a laparoscopic approach has been inve...
关键词：Liver neoplasms HEPATECTOMY laparoscopic liver resection open liver resection 
ESMO 2023 pancreatic cancer guidelines signal stepwise progress
《Hepatobiliary Surgery and Nutrition》2024年第2期362-365,共4页Christoph Springfeld Peter Bailey Markus W.Büchler John P.Neoptolemos 
Pancreatic ductal adenocarcinoma(PDAC)is still a devastating disease,and for those who treat PDAC patients it sometimes seems that there is little to no relevant progress.The excellent new ESMO clinical practice guide...
关键词：Resectable BORDERLINE ADJUVANT NEOADJUVANT persister cells 
Molecular pathology for cholangiocarcinoma:a review of actionable genetic targets and their relevance to adjuvant&neoadjuvant therapy,staging,follow-up,and determination of minimal residual disease被引量：1
《Hepatobiliary Surgery and Nutrition》2024年第1期29-38,共10页Emilie A.K.Warren Shishir K.Maithel 
Cholangiocarcinoma(CCA)represents a group of epithelial cell tumors classified based on their anatomic location along the biliary tree.This rare malignancy is often diagnosed at an advanced stage and deemed unresectab...
关键词：Cholangiocarcinoma(CCA) biliary tract cancer(BTC) targeted therapy molecular profiling 
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma被引量：1
《Hepatobiliary Surgery and Nutrition》2023年第3期435-439,共5页Masatoshi Kudo 
Hepatectomy and radiofrequency ablation(RFA)are established curative methods for hepatocellular carcinoma(HCC).However,the recurrence rate of HCC is high even in patients who undergo these curative therapies,with HCC ...
关键词：Hepatocellular carcinoma atezolizumab plus bevacizumab adjuvant therapy RESECTION ablation 
Trends in the use of adjuvant therapy for resected intrahepatic cholangiocarcinoma: getting ahead of the data被引量：1
《Hepatobiliary Surgery and Nutrition》2021年第4期515-517,共3页Jordan M.Cloyd Timothy M.Pawlik 
Intrahepatic cholangiocarcinoma(ICC),the second most common primary liver malignancy,is an aggressive cancer occurring with increasing global incidence.Significant advances in our understanding of its pathogenesis and...
关键词：HEPATIC ADJUVANT PATHOGENESIS 
Ampullary adenocarcinoma:the current state of adjuvant therapies
《Hepatobiliary Surgery and Nutrition》2020年第5期647-649,共3页Charles C.Vining Darryl Schuitevoerder Kiran K.Turaga 
Periampullary cancers,including adenocarcinoma from the duodenum,pancreas,bile duct and ampulla,represent a spectrum of malignancies with varying biological behavior and outcomes.In particular ampullary adenocarcinoma...
关键词：ADENOCARCINOMA ADJUVANT PANCREAS 
The future of adjuvant therapy in ampullary cancer: should we offer it to our patients?
《Hepatobiliary Surgery and Nutrition》2020年第3期368-370,共3页Sri Harsha Tella Amit Mahipal 
Ampullary carcinoma is a relatively rare and heterogenous neoplasm accounting for 0.2%of all gastrointestinal tract malignancies.
关键词：ADJUVANT PATIENTS NEOPLASM 
Expanding treatment strategies for hepatocellular carcinoma patients: postoperative adjuvant transarterial chemoembolization被引量：2
《Hepatobiliary Surgery and Nutrition》2020年第1期59-61,共3页Rodolfo Sacco Antonio Facciorusso 
In spite of the recent improvements in diagnostic and treatment options for hepatocellular carcinoma (HCC) patients, with an increasing number of patients diagnosed in early stage and offered more effective therapies,...
关键词：PATIENTS HEPATOCELLULAR treatment 
Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion被引量：32
《Hepatobiliary Surgery and Nutrition》2018年第6期418-428,共11页Han Wang Peng-Cheng Du Meng-Chao Wu Wen-Ming Cong 
National Natural Science Foundation of China(grant No.81472278);Funds for Creative Research Groups of National Natural Science Foundation of China(grant No.81521091).
Background:The survival benefit of postoperative adjuvant transcatheter arterial chemoembolization(PA-TACE)remained controversial.We aimed to investigate the prognosis effect of PA-TACE on the Barcelona Clinic Liver C...
关键词：Hepatocellular carcinoma(HCC) MICROVASCULAR invasion(MVI) CLONAL origin POSTOPERATIVE ADJUVANT transcatheter arterial chemoembolization(PA-TACE) 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部